In an open-label study in depressed patients with BD (N = 34) receiving pioglitazone (15–30 mg/day), higher baseline IL-6 was associated with a favourable antidepressant response and improvement in insulin resistance [70]. The gene discussed is IL6; the disease is Insulin resistance.